FDA Adverse Event Injury Summary report: N

BIOMET PATELLA 1/4 INCH PEG

MDR report key: 7307462 · Received March 1, 2018

Report

Report Number
0001825034-2018-01603
Event Type
Injury
Date Received
March 1, 2018
Date of Event
August 18, 2017
Report Date
March 2, 2018
Manufacturer
ZIMMER BIOMET, INC.
Product Code
JWH
PMA / PMN Number
PK171054
Removal / Correction Number
N/A
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MO, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4) THE FOLLOWING REPORT IS SUBMITTED TO RELAY ADDITIONAL INFORMATION. CONCOMITANT MEDICAL PRODUCTS: VANGUARD CR ILOK FEM-RT 62.5 ITEM#183006 LOT#J6006473, VNGD ANT STAB BRG 13X71 LOT#890670 ITEM#189063, BIOMET CC I-BEAM TRAY 71MM LOT#J080209 ITEM#141223. THE REPORTED EVENT COULD NOT BE CONFIRMED BASED ON LIMITED INFORMATION RECEIVED. NO PRODUCTS WERE RETURNED; THEREFORE, THE VISUAL AND DIMENSIONAL INSPECTIONS WERE NOT PERFORMED. DEVICE HISTORY RECORD (DHR) WAS REVIEWED AND NO DISCREPANCIES RELEVANT TO THE REPORTED EVENT WERE FOUND. REVIEW OF THE COMPLAINT HISTORY DETERMINED THAT NO FURTHER ACTION IS REQUIRED. A DEFINITIVE ROOT CAUSE CANNOT BE DETERMINED WITH THE INFORMATION PROVIDED. NO CORRECTIVE ACTIONS, PREVENTIVE ACTIONS, OR FIELD ACTIONS RESULTED AFTER INVESTIGATION OF THIS EVENT. IF ANY FURTHER INFORMATION IS FOUND WHICH WOULD CHANGE OR ALTER ANY CONCLUSIONS OR INFORMATION, A SUPPLEMENTAL WILL BE FILED ACCORDINGLY. ZIMMER BIOMET WILL CONTINUE TO MONITOR FOR TRENDS. MULTIPLE MDR REPORTS WERE FILED FOR THIS EVENT, PLEASE SEE ASSOCIATED REPORTS: 0001825034-2018-00649, 0001825034-2018-00651, 0001825034-2018-00650.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT DEVELOPED A PULMONARY EMBOLISM ONE WEEK FOLLOWING INITIAL IMPLANTATION. ATTEMPTS HAVE BEEN MADE AND NO FURTHER INFORMATION HAS BEEN PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
150172 BIOMET PATELLA 1/4 INCH PEG KNEE, PROSTHESIS JWH ZIMMER BIOMET, INC. N/A 588380

Patients

Seq Age Sex Outcome Treatment
1 67 YR Required Intervention